228467 Finsbury WWH pp70-pp73 18 06 2013 10:42 Page 73 Company Information 73 Company Information DIREC TORS AUDITORS Sir Martin Smith Chairman Ernst & Young LLP Sarah Bates 1 More London Place Jo Dixon London SE1 2AF Dr David Holbrook Samuel D. Isaly REGISTRARS Doug McCutcheon Capita Registrars Anthony Townsend The Registry 34 Beckenham Road COMPANY REGISTRATION NUMBER Beckenham 3023689 Registered in England Kent BR3 4TU The Company is an investment company as defined under Telephone in UK : 0871 664 0300 Section 833 of the Companies Act 2006 Telephone from overseas : 44 208 639 3399 Facsimile: 44 0 1484 600911 The Company was incorporated in England and Wales on E-mail: ssd@capitaregistrars.
The Company was incorporated as Website: www.
com Finsbury Worldwide Pharmaceutical Trust PLC.
Please contact the Registrars if you have a query about a WEBSITE certificated holding in the Companys shares.
com calls cost 10p per minute plus network charges and may be recorded for training purposes.
Lines are open from 8.30 a. m. to 5.30 p. m. Monday to Friday.
REGISTERED OFFICE One Wood Street London EC2V 7WS STOCKBROKER Winterflood Securities Limited The Atrium Building INVESTMENT MANAGER Cannon Bridge, 25 Dowgate Hill OrbiMed Capital LLC London EC4R 2GA 601 Lexington Avenue, 54th Floor New York NY 10022 Website: www.
com SHARE AND SUBSCRIPTION SHARE PRICE Registered under the U. S. Securities & Exchange Commission LISTINGS The price of your shares and subscription shares can be found in MANAGER, ADMINISTRATOR AND COMPANY various publications including the Financial Times, The Daily SECRE TARY Telegraph, The Times and The Scotsman.
Frostrow Capital LLP The Companys net asset value per share is announced daily and 25 Southampton Buildings, London WC2A 1AL is available, together with the share price, on the TrustNet Telephone: 0203 008 4910 website at www.
com Authorised and regulated by the Financial Conduct Authority IDENTIFICATION CODES Shares: SEDOL : 0338530 If you have an enquiry about the Company or if you would like to ISIN : GB0003385308 receive a copy of the Companys monthly fact sheet by e-mail, BLOOMBERG : WWH LN please contact Frostrow Capital using the above e-mail address.
EPIC : WWH Subscription Shares: SEDOL : B3VMCB0 CUSTODIAN AND BANKER ISIN : GB00B3VMCB07 Goldman Sachs & Co. BLOOMBERG : WWHS LN 200 West Street, Third Floor New York, NY10282 LISTED PREMIUM DISABILITY ACT Copies of this annual report and other documents issued by the Company are available from the Company Secretary.
If needed, copies can be made available in a variety of formats, including Braille, audio tape or larger type as appropriate.
You can contact the Registrar to the Company, Capita Registrars, which has installed telephones to allow speech and hearing impaired people who have their own telephone to contact them directly, without the need for an intermediate operator, for this service please call 0800 731 1888.
Specially trained operators are available during normal business hours to answer queries via this service.
Alternatively, if you prefer to go through a typetalk operator provided by the RNID you should dial 18001 followed by the number you wish to dial.
Worldwide Healthcare Trust PLC Annual Report 2013 WORLDWIDE HEALTHCARE TRUST PLC ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2013 228467 Finsbury WWH Cover 18 06 2013 07:19 Page 1 WORLDWIDE HEALTHCARE TRUST PLC ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2013 The Company is a member of the Association of Investment Companies.
Worldwide Healthcare Trust PLC 25 Southampton Buildings, London WC2A 1AL www.
com 228467 Finsbury WWH Cover 18 06 2013 07:19 Page 2 CONTENTS ACCESSING THE GLOBAL MARKE T ANNUAL REPORT ss t s The healthcare sector is a global one and acce ing hi global Financial Highlights 1 a t as a nv sto can ff cu t. th n th, th a m rke UK i e r be di i l Wi i e UK ere re Chairmans Statement 2-3 diminishing options for investment as the unive se of r OrbiMed Capital LLC - Investment Manager 4 healthcare companies is shrinking through mergers and Review of Investments 5-10 acquisitions.
Worldwide Healthcare Trust PLC offers an Historic Performance 11 opportunity to gain exposure to pharmaceutical, Champions of Innovation 12-13 biotechnology and related companies in the healthcare sector Portfolio 14-16 on a global scale.
Analysis of the Portfolio 17 Your Board 18 REPORT OF THE DIRECTORS AND FINANCIAL STATEMENTS INVESTMENT OBJEC TIVE AND Report of the Directors Incorporating the Business Review 19-28 POLICY Statement of Directors Responsibilities 29 Worldwide Healthcare Trust PLC invests in the global Corporate Governance 30-35 healthcare sector with the objective of achieving a high level Shareholder Analysis 36 of capital growth.
In order to achieve its investment objective, Directors Remuneration Report 37-38 the Company invests worldwide in a diversified portfolio of Independent Auditors Report39-40 shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
It uses gearing and Income Statement 41 derivative transactions to mitigate risk and also to enhance Reconciliation of Movements in Shareholders Funds 42 returns.
Performance is measured against the MSCI World Balance Sheet 43 Health Care Index on a net total return, sterling adjusted basis.
Cash Flow Statement 44 Further details of the Companys investment policy are set out Notes to the Financial Statements 45-60 in the Report of the Directors beginning on page 19.
GENERAL INFORMATION Explanatory Notes of the Principal Changes to the Companys Articles of Association 61 Notice of Annual General Meeting 62-67 CONTINUATION VOTE Notice of Separate Meeting of Subscription The next continuation vote of the Company shall be held at Shareholders 68-69 the Annual General Meeting in 2014, and further How to Invest 70-71 opportunities to vote on the continuation of the Company Glossary 72 shall be given to shareholders every five years thereafter.
Company Information 73 GEARING FINANCIAL CALENDAR The Companys borrowing requirements are met through the Financial Year End 31 March utilisation of a loan facility, repayable on demand provided by Goldman Sachs & Co. New York.
At 31 March 2013 31.4m was Financial Results Announced June drawn down from this facility.
Half Year End 30 September Half Year Results Announced November Interim Management Statements Announced February August ISA STATUS Dividends payable January July The Companys shares are eligible for inclusion in Individual 2013 Annual General Meeting Savings Accounts ISAs and for Junior ISAs.
Further Wednesday, 17 July information on how to invest in the Company can be found to be held at, beginning on page 70. the Carpenters Hall This report is printed on Revive Pure White Silk a totally recycled paper produced using 100% recycled Throgmorton Avenue, London waste at a mill that has been awarded the ISO 14001 certificate for environmental management.
EC2N 2JJ WEBSITE The pulp is bleached using a totally chlorine free TCF process.
The Companys internet address is www.
